Search Results

The YUKON OCT Spinal System is intended to provide immobilization of spinal segments as an adjunct to fusion for the following acute and chronic instabilities of the craniocervical junction, the cervical spine (C1 to C7) and the thoracic spine (T1-T3); traumatic spinal fractures and/or traumatic dislocations; instability or deformity; failed previous fusion (e.g., pseudoarthrosis); tumors involving the cervical spine; and degenerative disease, including intractable radiculopathy and/or myelopathy, neck and/or arm pain of discogenic origin as confirmed by radiographic studies, and degenerative disease of the facets with instability.

The YUKON OCT Spinal System is also intended to restore the integrity of the spinal column even in the absences of fusion for a limited time period in patients with advanced stage tumors involving the cervical spine in whom life expectancy is of insufficient duration to permit achievement of fusion.

In order to achieve additional levels of fixation, the YUKON OCT Spinal System may be connected to EVEREST, MESA, and DENALI Spinal System components via the rod to rod connectors or transition rods.

The YUKON OCT Spinal System is a top-loading, multiple component, posterior (occipital-cervical-thoracic) spinal fixation system consisting of screws, hooks, rods, rod connectors, and occipital components. The system functions as an adjunct to fusion to provide stablilization of the posterior cervical and thoracic spine.

I apologize, but the provided text does not contain information about the acceptance criteria or a study proving that a device meets those criteria.

The document is an FDA 510(k) clearance letter for the "Yukon OCT Spinal System." It details the device's classification, indications for use, and a summary of technological characteristics and non-clinical performance evaluation, which states:

• Non-clinical Performance Evaluation: "The subject implants were compared to the predicates using engineering rationales in addition to static compression, static torsion and dynamic compression testing (ASTM F1717) and performed equivalent to or better than the predicates."

This statement indicates that the device underwent non-clinical (mechanical) testing based on ASTM F1717 standards and demonstrated performance equivalent to or better than predicate devices. However, it does not specify:

• Quantitative acceptance criteria (e.g., specific load endurance, displacement limits).
• The raw performance data of the device against these criteria.
• Details about a clinical study, including sample sizes, ground truth establishment, expert qualifications, or comparative effectiveness studies (MRMC, standalone algorithm performance).

Therefore, I cannot fulfill your request for the specific details outlined in your prompt based on the provided text.

Ask a specific question about this device